DeutschNewstral
Article
bizjournals.com on 2020-12-17 17:26
Philadelphia gene therapy firm Passage Bio signs lease deal for lab space in New Jersey
Related news
- Passage Bio further expands gene therapy research partnership with Pennbizjournals.com
- Philadelphia’s 'hungry' cell and gene therapy companies seek more lab space, capital to fuel growthbizjournals.com
- Gene therapy developer Passage Bio adds a trio to its C-suitebizjournals.com
Gene therapy retina disease potentialBBC
Gene therapy helps inherited blindnesspressherald.com- Gene therapy startup Passage Bio raises $110M Series B, its second raise in less than a yearbizjournals.com
Could experimental gene therapy treat blindness?CNN- US: Gene therapy approved for cancer treatmentCNN
Here’s What’s Next for Gene Therapyphillymag.com- Philadelphia gene therapy startup plans $125M IPObizjournals.com
- ACorrection: Genetic Frontiers-Blindness-Gene Therapy storyapnewsarchive.com
- Gene therapy company plans $15M stock salebizjournals.com
- AUS clears breakthrough gene therapy for childhood leukemiaapnewsarchive.com
Spark's Luxturna first gene therapy for inherited eye diseasecleveland.com- BBluebird Bio Suspends Gene Therapy Trials, Marketing After Cancer Diagnosisbarrons.com
- FBluebird Bio prices gene therapy at nearly $1.8mft.com
- BIO 2019: Gene therapy surging, but challenges remainbizjournals.com
- Cambridge gene therapy firm bluebird bio to move to Somervillebizjournals.com
- Spark Therapeutics sues gene therapy rival Bluebird Biobizjournals.com
- Bluebird bio sued by gene therapy rival Spark Therapeuticsbizjournals.com